Liem KS - Search Results

1

[Applications of 'quantitative sensory testing'].

Verberne WR, Snijders TJ, Liem KS, Baakman AC, Veldhuijzen DS. Verberne WR, et al. Among authors: liem ks. Ned Tijdschr Geneeskd. 2013;157(5):A5434. Ned Tijdschr Geneeskd. 2013. PMID: 23369816 Review. Dutch.

2

[Boerhaave's syndrome: also in the emergency room].

van Winkel AT, Meijs MM, Hesselink EJ, Bendien C, Liem KS. van Winkel AT, et al. Among authors: liem ks. Ned Tijdschr Geneeskd. 2001 Mar 10;145(10):449-53. Ned Tijdschr Geneeskd. 2001. PMID: 11268904 Dutch.

3

'Virtual lesion' in pain research; a study on magnetic stimulation of the primary motor cortex.

Granovsky Y, Liem KS, Weissman-Fogel I, Yarnitsky D, Chistyakov A, Sinai A. Granovsky Y, et al. Among authors: liem ks. Eur J Pain. 2016 Feb;20(2):241-9. doi: 10.1002/ejp.715. Epub 2015 Apr 27. Eur J Pain. 2016. PMID: 25919687 Clinical Trial.

4

[Myocardial abscess as complication of infectious endocarditis].

Liem KS, Sindram MT, van Douveren WA, Fedder G. Liem KS, et al. Ned Tijdschr Geneeskd. 1979 May 19;123(20):831-6. Ned Tijdschr Geneeskd. 1979. PMID: 440469 Dutch. No abstract available.

5

Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.

Ipenburg NA, Koole K, Liem KS, van Kempen PM, Koole R, van Diest PJ, van Es RJ, Willems SM. Ipenburg NA, et al. Among authors: liem ks. Target Oncol. 2016 Feb;11(1):17-27. doi: 10.1007/s11523-015-0374-9. Target Oncol. 2016. PMID: 26115874 Free PMC article. Review.

6

[Lithium, a potentially dangerous drug].

Liem KS. Liem KS. Ned Tijdschr Geneeskd. 2005 Apr 30;149(18):1017-8; author reply 1018-9. Ned Tijdschr Geneeskd. 2005. PMID: 15903046 Dutch. No abstract available.

7

[Electrocardiographical changes during lithiumcarbonate therapy].

Liem KS, van der Does de Willebois JA. Liem KS, et al. Ned Tijdschr Geneeskd. 1975 Sep 27;119(39):1509-12. Ned Tijdschr Geneeskd. 1975. PMID: 1178085 Dutch. No abstract available.

8

Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study).

Farag MS, van Campenhout MJH, Sonneveld MJ, Fung S, van Erpecum KJ, Wong DK, Verhey E, de Man R, De Knegt RJ, Brouwer JT, Baak HC, Feld JJ, Liem KS, Boonstra A, Hansen BE, Janssen HLA. Farag MS, et al. Among authors: liem ks. J Viral Hepat. 2024 Apr;31(4):197-207. doi: 10.1111/jvh.13918. Epub 2024 Jan 19. J Viral Hepat. 2024. PMID: 38243144 Clinical Trial.

9

Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy.

Majeed NA, Alawad AS, Liem KS, Takyar V, Alter H, Feld JJ, Janssen HLA, Ghany MG. Majeed NA, et al. Among authors: liem ks. Dig Dis Sci. 2023 Jul;68(7):3193-3198. doi: 10.1007/s10620-023-07916-2. Epub 2023 Apr 6. Dig Dis Sci. 2023. PMID: 37022602

10

Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B.

Liem KS, Chi H, Fung S, Wong DK, Yim C, Noureldin S, Chen J, de Man RA, Sarowar A, Feld JJ, Hansen BE, Hou J, Peng J, Janssen HLA. Liem KS, et al. J Viral Hepat. 2022 Nov;29(11):986-993. doi: 10.1111/jvh.13742. Epub 2022 Sep 14. J Viral Hepat. 2022. PMID: 36048970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page